The company said it completed the acquisition of Inari Medical, Inc. with Eagle 1 Merger Sub, Inc. on February 19, 2025. At the closing, Merger Sub merged into Inari, and Inari remained as the surviving company.

1. 01

   The company said it completed the acquisition of Inari Medical, Inc. with Eagle 1 Merger Sub, Inc. on February 19, 2025. At the closing, Merger Sub merged into Inari, and Inari remained as the surviving company.

2. 02

   Stryker said the total consideration paid by or on behalf of Stryker and Merger Sub in the transaction was about $4.94 billion in cash.

3. 03

   Stryker said the acquisition was completed under the Agreement and Plan of Merger dated as of January 6, 2025. The merger was carried out under Section 251(h) of the Delaware General Corporation Law, and Merger Sub executed a joinder on January 7, 2025.

4. 04

   The company said the full text of the merger agreement was filed as Exhibit 2.1 to Form 8-K dated January 7, 2025. The report was signed on February 19, 2025 by Glenn S. Boehnlein, Vice President and Chief Financial Officer.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.